Sex Cord-Stromal Tumor — Trials

Sex Cord-Stromal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05348356	Nirogacestat in Ovarian Granulosa Cell Tumors	completed	Phase 2	53	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	3	Aug 25, 2026	clinicaltrials
NCT03926936	FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study(FUCHSia)	completed	Phase 2	17	Frederic AmantOTHER	2	May 28, 2024	clinicaltrials
NCT01770301	Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)(ALIENOR)	completed	Phase 2	60	ARCAGY/ GINECO GROUPOTHER	1	Jul 2, 2021	clinicaltrials

Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials